Jesús G. Berdeja

18.2k citations
257 papers · 5.0k indexed · 1 hit paper · h-index 40
Topics
Multiple Myeloma Research and Treatments (174 papers)Protein Degradation and Inhibitors (96 papers)CAR-T cell therapy research (82 papers)
Journals
New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations
United StatesSpainCanada

In The Last Decade

Jesús G. Berdeja

243 papers receiving 4.9k citations

Hit Papers

Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antib...20222026202320242022100200300

Peers

Jesús G. Berdeja
Comparison fields: 5 of 79
  • Molecular Biology 3.1k
  • Oncology 3.0k
  • Hematology 2.9k
  • Immunology 717
  • Radiology, Nuclear Medicine and Imaging 584
Replace Bruno Paiva with:
Bruno Paiva Spain
Tahamtan Ahmadi United States
Richard W.J. Groen Netherlands
Shmuel Yaccoby United States
Jacalyn Rosenblatt United States
Michael H. Tomasson United States
María‐Belén Vídriales Spain
Salomon Manier France
Hetty E. Carraway United States
Martin Wermke Germany
Jesús G. Berdeja relative to Bruno Paiva Spain Bruno Paiva's profile →
Citations per field
00.5×3.8×
Bruno Paiva · 1×
Citations per year

Countries citing papers authored by Jesús G. Berdeja

Since Specialization
Citations

This map shows the geographic impact of Jesús G. Berdeja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús G. Berdeja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús G. Berdeja more than expected).

Fields of papers citing papers by Jesús G. Berdeja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesús G. Berdeja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús G. Berdeja. The network helps show where Jesús G. Berdeja may publish in the future.

Co-authorship network of co-authors of Jesús G. Berdeja

This figure shows the co-authorship network connecting the top 25 collaborators of Jesús G. Berdeja. A scholar is included among the top collaborators of Jesús G. Berdeja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús G. Berdeja. Jesús G. Berdeja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 1
4 1
5 1
6 1
7 2
8 4
9 0
10 1
11 4
12 2
13 66
14 24
15 39
16 33
17 83
18 157
19 6
20 38

About Jesús G. Berdeja

Jesús G. Berdeja is a scholar working on Hematology, Genetics and Oncology, having authored 257 papers that have together received 5.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (174 papers), Protein Degradation and Inhibitors (96 papers) and CAR-T cell therapy research (82 papers). The work is most often cited by research in Hematology (2.9k citations), Oncology (3.0k citations) and Genetics (536 citations). Jesús G. Berdeja has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include David S. Siegel, Noopur Raje, Sundar Jagannath, Paul G. Richardson, Ian W. Flinn, Jonathan L. Kaufman, Yi Lin, Sagar Lonial, Ravi Vij and Amrita Krishnan. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026